All companies › IMAX

IMAX · IMAX CORP

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells8
Research cases0
Last filing2026-09-10

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-18 — GELFOND RICHARD L · sold 151,253 @ $51.00 2026-08-19 — GELFOND RICHARD L · sold 205,504 @ $53.27 2026-08-20 — PABLO CALAMERA · sold 15,000 @ $52.41 2026-08-20 — GELFOND RICHARD L · sold 100,000 @ $53.23 2026-08-24 — Fernandes Natasha · sold 20,000 @ $54.63 2026-08-25 — Weissman Kenneth Ian · sold 8,000 @ $54.54 2026-08-25 — WELTON MARK · sold 30,000 @ $54.47 2026-09-10 — LISTER ROBERT D · sold 22,500 @ $51.58
2026-08-182026-09-10

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

GELFOND RICHARD L Chief Executive Officer, Director
PABLO CALAMERA CTO & EVP
Fernandes Natasha Chief Financial Officer & EVP
Weissman Kenneth Ian Deputy GC, Corp. Sec. & CCO
WELTON MARK President IMAX Global Theatres
LISTER ROBERT D Chief Legal Officer Sr Exec VP
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $IMAX is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-10', 'insider_name': 'LISTER ROBERT D', 'insider_title': 'Chief Legal Officer Sr Exec VP', 'transaction_type': 'Open-market sell', 'shares': 22500.0, 'price': 51.58, 'value': 1160550.0, 'is_buy': False}, {'transaction_date': '2026-08-25', 'insider_name': 'Weissman Kenneth Ian', 'insider_title': 'Deputy GC, Corp. Sec. & CCO', 'transaction_type': 'Open-market sell', 'shares': 8000.0, 'price': 54.54, 'value': 436320.0, 'is_buy': False}, {'transaction_date': '2026-08-25', 'insider_name': 'WELTON MARK', 'insider_title': 'President IMAX Global Theatres', 'transaction_type': 'Open-market sell', 'shares': 30000.0, 'price': 54.47, 'value': 1634100.0, 'is_buy': False}, {'transaction_date': '2026-08-24', 'insider_name': 'Fernandes Natasha', 'insider_title': 'Chief Financial Officer & EVP', 'transaction_type': 'Open-market sell', 'shares': 20000.0, 'price': 54.63, 'value': 1092600.0, 'is_buy': False}, {'transaction_date': '2026-08-20', 'insider_name': 'PABLO CALAMERA', 'insider_title': 'CTO & EVP', 'transaction_type': 'Open-market sell', 'shares': 15000.0, 'price': 52.41, 'value': 786150.0, 'is_buy': False}, {'transaction_date': '2026-08-20', 'insider_name': 'GELFOND RICHARD L', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 100000.0, 'price': 53.23, 'value': 5323000.0, 'is_buy': False}, {'transaction_date': '2026-08-19', 'insider_name': 'GELFOND RICHARD L', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 205504.0, 'price': 53.27, 'value': 10947198.08, 'is_buy': False}, {'transaction_date': '2026-08-18', 'insider_name': 'GELFOND RICHARD L', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 151253.0, 'price': 51.0, 'value': 7713903.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for IMAX today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.